Protective Roles of Epithelial Cells in the Survival of Adult T-Cell Leukemia/Lymphoma Cells

Poiesz, 1980, Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma, Proc Natl Acad Sci U S A, 77, 7415, 10.1073/pnas.77.12.7415 Yoshida, 1982, Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease, Proc Natl Acad Sci U S A, 79, 2031, 10.1073/pnas.79.6.2031 Uchiyama, 1977, Adult T-cell leukemia: clinical and hematologic features of 16 cases, Blood, 50, 481, 10.1182/blood.V50.3.481.481 Bittencourt, 2010, Cutaneous manifestations associated with HTLV-1 infection, Int J Dermatol, 49, 1099, 10.1111/j.1365-4632.2010.04568.x Ohshima, 2007, Pathological features of diseases associated with human T-cell leukemia virus type I, Cancer Sci, 98, 772, 10.1111/j.1349-7006.2007.00456.x Nasr, 2011, Controversies in targeted therapy of adult T cell leukemia/lymphoma: ON target or OFF target effects?, Viruses, 3, 750, 10.3390/v3060750 Taniguchi, 2005, Silencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanisms, Retrovirology, 2, 64, 10.1186/1742-4690-2-64 Furukawa, 1995, Human T-cell leukemia virus type-1 (HTLV-1) Tax is expressed at the same level in infected cells of HTLV-1-associated myelopathy or tropical spastic paraparesis patients as in asymptomatic carriers but at a lower level in adult T-cell leukemia cells, Blood, 85, 1865, 10.1182/blood.V85.7.1865.bloodjournal8571865 Gessain, 1991, Human T-cell leukemia-lymphoma virus type I (HTLV-I) expression in fresh peripheral blood mononuclear cells from patients with tropical spastic paraparesis/HTLV-I-associated myelopathy, J Virol, 65, 1628, 10.1128/JVI.65.3.1628-1633.1991 Nagai, 2008, Adhesion-dependent growth of primary adult T cell leukemia cells with down-regulation of HTLV-I p40Tax protein: a novel in vitro model of the growth of acute ATL cells, Int J Hematol, 88, 551, 10.1007/s12185-008-0207-z Kinpara, 2009, Stromal cell-mediated suppression of human T-cell leukemia virus type 1 expression in vitro and in vivo by type I interferon, J Virol, 83, 5101, 10.1128/JVI.02564-08 Michael, 2006, Histone acetyltransferase (HAT) activity of p300 modulates human T lymphotropic virus type 1 p30II-mediated repression of LTR transcriptional activity, Virology, 354, 225, 10.1016/j.virol.2006.07.002 Ego, 2002, The interaction of HTLV-1 Tax with HDAC1 negatively regulates the viral gene expression, Oncogene, 21, 7241, 10.1038/sj.onc.1205701 Mosley, 2006, Histone deacetylase inhibitors increase virus gene expression but decrease CD8+ cell antiviral function in HTLV-1 infection, Blood, 108, 3801, 10.1182/blood-2006-03-013235 Panayiotidis, 1996, Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro, Br J Haematol, 92, 97, 10.1046/j.1365-2141.1996.00305.x Lagneaux, 1998, Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells, Blood, 91, 2387, 10.1182/blood.V91.7.2387 Burger, 2000, Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1, Blood, 96, 2655, 10.1182/blood.V96.8.2655 Kawaguchi, 2009, Inhibition of the SDF-1alpha-CXCR4 axis by the CXCR4 antagonist AMD3100 suppresses the migration of cultured cells from ATL patients and murine lymphoblastoid cells from HTLV-I Tax transgenic mice, Blood, 114, 2961, 10.1182/blood-2008-11-189308 Wayner, 1993, Epiligrin, a component of epithelial basement membranes, is an adhesive ligand for alpha 3 beta 1 positive T lymphocytes, J Cell Biol, 121, 1141, 10.1083/jcb.121.5.1141 Suck, 2005, KHYG-1, a model for the study of enhanced natural killer cell cytotoxicity, Exp Hematol, 33, 1160, 10.1016/j.exphem.2005.06.024 Sheehy, 2006, Functional analysis of human T lymphotropic virus type 2 Tax proteins, Retrovirology, 3, 20, 10.1186/1742-4690-3-20 Green, 2003, Exercise-induced changes to in vitro T-lymphocyte mitogen responses using CFSE, J Appl Physiol, 95, 57, 10.1152/japplphysiol.00011.2003 Schneider, 2012, NIH Image to ImageJ: 25 years of image analysis, Nat Methods, 9, 671, 10.1038/nmeth.2089 Sowa, 1999, Sp3, but not Sp1, mediates the transcriptional activation of the p21/WAF1/Cip1 gene promoter by histone deacetylase inhibitor, Cancer Res, 59, 4266 Mani, 2008, The epithelial-mesenchymal transition generates cells with properties of stem cells, Cell, 133, 704, 10.1016/j.cell.2008.03.027 Ferrari, 1986, Coding sequence and growth regulation of the human vimentin gene, Mol Cell Biol, 6, 3614, 10.1128/MCB.6.11.3614 Su, 2011, Direct reprogramming of stem cell properties in colon cancer cells by CD44, EMBO J, 30, 3186, 10.1038/emboj.2011.211 Lee, 2009, Acetylation and activation of STAT3 mediated by nuclear translocation of CD44, J Cell Biol, 185, 949, 10.1083/jcb.200812060 Gleimer, 2003, Stress management: MHC class I and class I like molecules as reporters of cellular stress, Immunity, 19, 469, 10.1016/S1074-7613(03)00272-3 Raulet, 2009, Oncogenic stress sensed by the immune system: role of natural killer cell receptors, Nat Rev Immunol, 9, 568, 10.1038/nri2604 Bauer, 1999, Activation of NK cells and T cells by NKG2D, a receptor for stress inducible MICA, Science, 285, 727, 10.1126/science.285.5428.727 Marks, 2000, Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells, J Natl Cancer Inst, 92, 1210, 10.1093/jnci/92.15.1210 Shakespear, 2011, Histone deacetylases as regulators of inflammation and immunity, Trends Immunol, 32, 335, 10.1016/j.it.2011.04.001 Eot-Houllier, 2009, Histone deacetylase inhibitors and genomic instability, Cancer Lett, 274, 169, 10.1016/j.canlet.2008.06.005 Solis, 2012, Hyaluronan regulates cell behavior: a potential niche matrix for stem cells, Biochem Res Int, 2012, 346972, 10.1155/2012/346972 Chagan-Yasutan, 2011, Involvement of osteopontin and its signaling molecule CD44 in clinicopathological features of adult T cell leukemia, Leuk Res, 35, 1484, 10.1016/j.leukres.2011.05.011 Olsen, 2007, Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma, J Clin Oncol, 25, 3109, 10.1200/JCO.2006.10.2434 Piekarz, 2011, Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma, Blood, 117, 5827, 10.1182/blood-2010-10-312603 Nishioka, 2008, Histone deacetylase inhibitors induce growth arrest and apoptosis of HTLV-1-infected T-cells via blockade of signaling by nuclear factor kappaB, Leuk Res, 32, 287, 10.1016/j.leukres.2007.05.026 Hasegawa, 2011, LBH589, a deacetylase inhibitor, induces apoptosis in adult T-cell leukemia/lymphoma cells via activation of a novel RAIDD-caspase-2 pathway, Leukemia, 25, 575, 10.1038/leu.2010.315